Lilly says Mounjaro and Zepbound contributed to big revenue boost
Lilly’s CEO says that the company has “tremendous momentum†entering 2025.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
